ARHGAP29 and breast carcinoma: In MCF-7-EMT breast cancer cells, a reduction in ARHGAP29 expression was demonstrated 120 h after ARHGAP29 knock-down (63.67 ± 16.23 SEM relative expression ARHGAP29/GAPDH in % vs. control; p = 0.0888; n = 3; Figure 4B).